全体要約
ハンチントン病の治療市場は、2022年から2029年にかけて成長が見込まれています。アメリカ、中国、ヨーロッパの各市場も同様に成長が予測されており、特にアメリカ市場は2022年から2029年にかけての成長率が注目されています。主要な企業には、AInylam Pharmaceuticals、Lundbeck、Teva Pharmaceuticalなどが含まれ、2022年には上位2社が市場の大部分を占めています。
ハンチントン病は、30歳から50歳の世代に大きな影響を与える遺伝性の神経変性疾患です。地域によって発症率に大きな差があり、アジアでは低く、ヨーロッパや北アメリカでは高い傾向があります。市場は、製品タイプやアプリケーション、地域別に細分化されており、病院や専門クリニックでの利用が見込まれています。
関連する質問
AInylam Pharmaceuticals Inc, AmpliPhi Biosciences Corp, Ceregene Inc, Lundbeck, Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd, Cortex Pharmaceuticals Inc, Vertex Pharmaceuticals Incorporated, Auspex Pharmaceuticals, SOM Biotech, GlaxoSmithKline, Siena Biotech, Raptor Pharmaceutical, Pfizer, Palobiofarma, Omeros, Ipsen, Valeant Pharmaceuticals International Inc
製品セグメンテーションのトレンド, 地域別市場成長の差異, 特定の治療法の需要増加
概要
ハンチントン病治療のアメリカ市場は、2022年のXX米ドルから2029年までにXX米ドルに増加することが見込まれており、2023年から2029年の間にCAGR%の成長率を示します。
中国のハンチントン病治療市場は、2022年のXX米ドルから2029年までにXX米ドルに増加し、2023年から2029年の間にXX%の CAGR で成長することが見込まれています。
ヨーロッパにおけるハンティントン病治療市場は、2022年のXX米ドルから2029年までにXX米ドルへと増加すると見込まれており、2023年から2029年までの間にXX%の年平均成長率（CAGR）を記録します。
世界の主要なハンチントン病治療のプレーヤーには、Ainylam Pharmaceuticals Inc、AmpliPhi Biosciences Corp、Ceregene Inc、Lundbeck、Prana Biotechnology Limited、Teva Pharmaceutical Industries Ltd、Cortex Pharmaceuticals Inc、Vertex Pharmaceuticals Incorporated、Auspex Pharmaceuticalsなどが含まれます。収益に関して、2022年において、世界の2社の大手企業が占めるシェアはほぼXX%でした。
ハンチントン病は、さまざまな世代に影響を及ぼすまれな遺伝性神経変性疾患です。この病気の影響は、30歳から50歳の年齢層で高く、働く能力、家族の世話、そして最終的には日常のタスクを完了する能力を妨げます。一般的な発生率は、地理的地域によって10倍以上の差があり、これは症例の確認方法や診断基準の違いに関連しています。その結果、一般集団における拡大した発生率は、思っているよりも大きい可能性があります。アジアの人口は、これまでずっと低い発生率を示しており、ヨーロッパ、北アメリカ、オーストラリアは高い発生率を示しています。
LPI (LP Information)の最新の調査報告書「ハンチントン病治療産業の予測」では、過去の売上を調査し、2022年の世界のハンチントン病治療の総売上をレビューし、2023年から2029年までの予測されるハンチントン病治療の売上に関する地域別および市場セクター別の包括的な分析を提供。地域、市場セクター、サブセクター別に分解されたハンチントン病治療の売上に基づいて、この報告書は世界のハンチントン病治療産業の詳細な分析をUS$百万単位で提供。
このインサイトレポートは、世界のハンチントン病治療市場の包括的な分析を提供し、製品セグメンテーション、企業形成、収益、市場シェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。このレポートは、ハンチントン病治療ポートフォリオと能力、市場参入戦略、市場ポジション、地理的なフットプリントに焦点を当て、主要なグローバル企業の戦略も分析しています。これにより、加速する世界のハンチントン病治療市場におけるこれら企業の独自の立ち位置をよりよく理解することができます。
このインサイトレポートは、ハンチントン病治療の世界的展望を形成する主要な市場トレンド、ドライバー、および影響要因を評価し、タイプ、アプリケーション、地理、マーケットサイズによる予測を分解して、新たな機会の出現ポケットを強調しています。数百のボトムアップの定性的および定量的市場データに基づいた透明性のある手法を用いて、この研究の予測は、グローバルなハンチントン病治療の現在の状態と将来の軌道に関する非常に微細な見解を提供します。
この報告書は、ハンチントン病治療市場の製品タイプ、アプリケーション、主要メーカー、主要地域および国による包括的な概要、市場シェア、および成長機会を示しています。
市場セグメンテーション:
タイプ別セグメンテーション
テトラベナジン
選択的セロトニン再取り込み阻害剤
クロルプロマジン
ハロペリドール
リスペリドン
オランザピン
クロザピン
その他
用途によるセグメンテーション
病院
専門クリニック
他の
この報告書では、市場を地域別に分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下にプロファイルされた企業は、一次専門家から収集した情報や企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析に基づいて選定されています。
アナイラムファーマシューティカルズ社
アンプリファイバイオサイエンス社
セレジーン株式会社
ルンドベック
プラナ・バイオテクノロジー・リミテッド
テバ・ファーマシューティカル・インダストリーズ・リミテッド
コルテックスファーマシューティカルズ株式会社
バーテックス・ファーマシューティカルズ・インコーポレーテッド
オスペックスファーマシューティカルズ
SOMバイオテック
グラクソ・スミスクライン
シエナバイオテック
ラプター製薬
ファイザー
パロビオファーマ
オメロス
イプセン
バレアント・ファーマシューティカルズ・インターナショナル・インク
本レポートで取り上げる主要な質問
グローバルハンチントン病治療市場の10年見通しは何ですか？
ハンティントン病治療市場の成長を促進している要因、世界的および地域別に。
市場と地域によって最も急速に成長する技術はどれですか？
ハンチントン病治療市場の機会は、最終市場規模によってどのように異なりますか？
ハンティントン病治療の種類、適用の内訳はどのようになっていますか？
COVID-19とロシア・ウクライナ戦争の影響は何ですか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルのハンチントン病の治療、年間売上、2018年～2029年
2.1.2 ハンチントン病の治療の世界市場の現状分析・将来予測、地理別、2018年、2022年および2029年
2.1.3 ハンチントン病の治療の世界市場の現状分析・将来予測、国・地域別、2018年、2022年および2029年
2.2 ハンチントン病の治療セグメント、タイプ別
2.2.1 テトラベナジン
2.2.2 選択的セロトニン再取り込み阻害薬
2.2.3 クロルプロマジン
2.2.4 ハロペリドール
2.2.5 リスペリドン
2.2.6 オランザピン
2.2.7 クロザピン
2.2.8 その他
2.3 ハンチントン病の治療の売上、タイプ別
2.3.1 グローバルにおけるハンチントン病の治療の売上・市場シェア、タイプ別（2018年～2023年）
2.3.2 ハンチントン病の治療のグローバルレベニュー・市場シェア、タイプ別（2018～2023年）
2.3.3 グローバルのハンチントン病の治療、販売価格（タイプ別）（2018年～2023年）
2.4 ハンチントン病の治療セグメント、用途別
2.4.1 病院
2.4.2 スペシャリティクリニック
2.4.3 その他
2.5 ハンチントン病の治療の売上、用途別
2.5.1 グローバルのハンチントン病の治療、収益・市場シェア（用途別）（2018年～2023年）
2.5.2 ハンチントン病の治療のグローバルレベニュー・市場シェア、用途別（2018～2023年）
2.5.3 グローバルのハンチントン病の治療、販売価格（用途別）（2018年～2023年）
3 グローバルにおけるハンチントン病の治療、企業別
3.1 グローバルにおけるハンチントン病の治療市場のブレークダウンデータ、企業別
3.1.1 グローバルにおけるハンチントン病の治療の年間売上、企業別（2018年～2023年）
3.1.2 グローバルにおけるハンチントン病の治療の売上・市場シェア、企業別（2018年～2023年）
3.2 グローバルにおけるハンチントン病の治療の年間収益、企業別（2018年～2023年）
3.2.1 グローバルにおけるハンチントン病の治療市場の収益規模、企業別（2018年～2023年）
3.2.2 グローバルにおけるハンチントン病の治療市場の収益シェア、企業別（2018年～2023年）
3.3 グローバルにおけるハンチントン病の治療の販売価格、企業別
3.4 ハンチントン病の治療の主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 ハンチントン病の治療の主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供しているハンチントン病の治療製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2018年～2023年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 ハンチントン病の治療の世界市場過去推移レビュー、地理別
4.1 ハンチントン病の治療の世界市場規模の過去推移、地理別（2018年～2023年）
4.1.1 グローバルにおけるハンチントン病の治療の年間売上、地理別（2018年～2023年）
4.1.2 グローバルにおけるハンチントン病の治療の年間収益、地理別（2018年～2023年）
4.2 ハンチントン病の治療の世界市場規模の過去推移、国・地域別（2018年～2023年）
4.2.1 グローバルにおけるハンチントン病の治療の年間売上、国・地域別（2018年～2023年）
4.2.2 グローバルにおけるハンチントン病の治療の年間収益、国・地域別（2018年～2023年）
4.3 アメリカズにおけるハンチントン病の治療の売上成長
4.4 APACにおけるハンチントン病の治療の売上成長
4.5 ヨーロッパにおけるハンチントン病の治療の売上成長
4.6 中東・アフリカにおけるハンチントン病の治療の売上成長
5 アメリカズ
5.1 アメリカズにおけるハンチントン病の治療の売上、国別
5.1.1 アメリカズにおけるハンチントン病の治療の売上規模、国別（2018年～2023年）
5.1.2 アメリカズにおけるハンチントン病の治療市場の収益規模、国別（2018年～2023年）
5.2 アメリカズにおけるハンチントン病の治療の売上、タイプ別
5.3 アメリカズにおけるハンチントン病の治療の売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおけるハンチントン病の治療の売上、地域別
6.1.1 APACにおけるハンチントン病の治療の売上規模、地域別（2018年～2023年）
6.1.2 APACにおけるハンチントン病の治療市場の収益規模、地域別（2018年～2023年）
6.2 APACにおけるハンチントン病の治療の売上、タイプ別
6.3 APACにおけるハンチントン病の治療の売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおけるハンチントン病の治療、国別
7.1.1 ヨーロッパにおけるハンチントン病の治療の売上規模、国別（2018年～2023年）
7.1.2 ヨーロッパにおけるハンチントン病の治療市場の収益規模、国別（2018年～2023年）
7.2 ヨーロッパにおけるハンチントン病の治療の売上、タイプ別
7.3 ヨーロッパにおけるハンチントン病の治療の売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおけるハンチントン病の治療、国別
8.1.1 中東・アフリカにおけるハンチントン病の治療の売上規模、国別（2018年～2023年）
8.1.2 中東・アフリカにおけるハンチントン病の治療市場の収益規模、国別（2018年～2023年）
8.2 中東・アフリカにおけるハンチントン病の治療の売上、タイプ別
8.3 中東・アフリカにおけるハンチントン病の治療の売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 ハンチントン病の治療の製造コスト構造分析
10.3 ハンチントン病の治療の製造プロセス分析
10.4 ハンチントン病の治療のインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 ハンチントン病の治療の流通業者
11.3 ハンチントン病の治療の顧客
12 ハンチントン病の治療の世界市場予測レビュー、地理別
12.1 グローバルにおけるハンチントン病の治療の市場規模予測、地域別
12.1.1 グローバルのハンチントン病の治療、市場予測（地域別）（2024年～2029年）
12.1.2 グローバルのハンチントン病の治療、年間収益予測（地域別）（2024年～2029年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおけるハンチントン病の治療の市場予測、タイプ別
12.7 グローバルにおけるハンチントン病の治療の市場予測、用途別
13 キープレイヤー分析
13.1 AInylam Pharmaceuticals Inc
13.1.1 AInylam Pharmaceuticals Inc：企業情報
13.1.2 AInylam Pharmaceuticals Inc：ハンチントン病の治療製品ポートフォリオと特徴
13.1.3 AInylam Pharmaceuticals Inc：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.1.4 AInylam Pharmaceuticals Inc：主要事業概要
13.1.5 AInylam Pharmaceuticals Inc：直近の展開
13.2 AmpliPhi Biosciences Corp
13.2.1 AmpliPhi Biosciences Corp：企業情報
13.2.2 AmpliPhi Biosciences Corp：ハンチントン病の治療製品ポートフォリオと特徴
13.2.3 AmpliPhi Biosciences Corp：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.2.4 AmpliPhi Biosciences Corp：主要事業概要
13.2.5 AmpliPhi Biosciences Corp：直近の展開
13.3 Ceregene Inc
13.3.1 Ceregene Inc：企業情報
13.3.2 Ceregene Inc：ハンチントン病の治療製品ポートフォリオと特徴
13.3.3 Ceregene Inc：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.3.4 Ceregene Inc：主要事業概要
13.3.5 Ceregene Inc：直近の展開
13.4 Lundbeck
13.4.1 Lundbeck：企業情報
13.4.2 Lundbeck：ハンチントン病の治療製品ポートフォリオと特徴
13.4.3 Lundbeck：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.4.4 Lundbeck：主要事業概要
13.4.5 Lundbeck：直近の展開
13.5 Prana Biotechnology Limited
13.5.1 Prana Biotechnology Limited：企業情報
13.5.2 Prana Biotechnology Limited：ハンチントン病の治療製品ポートフォリオと特徴
13.5.3 Prana Biotechnology Limited：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.5.4 Prana Biotechnology Limited：主要事業概要
13.5.5 Prana Biotechnology Limited：直近の展開
13.6 Teva Pharmaceutical Industries Ltd
13.6.1 Teva Pharmaceutical Industries Ltd：企業情報
13.6.2 Teva Pharmaceutical Industries Ltd：ハンチントン病の治療製品ポートフォリオと特徴
13.6.3 Teva Pharmaceutical Industries Ltd：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.6.4 Teva Pharmaceutical Industries Ltd：主要事業概要
13.6.5 Teva Pharmaceutical Industries Ltd：直近の展開
13.7 Cortex Pharmaceuticals Inc
13.7.1 Cortex Pharmaceuticals Inc：企業情報
13.7.2 Cortex Pharmaceuticals Inc：ハンチントン病の治療製品ポートフォリオと特徴
13.7.3 Cortex Pharmaceuticals Inc：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.7.4 Cortex Pharmaceuticals Inc：主要事業概要
13.7.5 Cortex Pharmaceuticals Inc：直近の展開
13.8 Vertex Pharmaceuticals Incorporated
13.8.1 Vertex Pharmaceuticals Incorporated：企業情報
13.8.2 Vertex Pharmaceuticals Incorporated：ハンチントン病の治療製品ポートフォリオと特徴
13.8.3 Vertex Pharmaceuticals Incorporated：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.8.4 Vertex Pharmaceuticals Incorporated：主要事業概要
13.8.5 Vertex Pharmaceuticals Incorporated：直近の展開
13.9 Auspex Pharmaceuticals
13.9.1 Auspex Pharmaceuticals：企業情報
13.9.2 Auspex Pharmaceuticals：ハンチントン病の治療製品ポートフォリオと特徴
13.9.3 Auspex Pharmaceuticals：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.9.4 Auspex Pharmaceuticals：主要事業概要
13.9.5 Auspex Pharmaceuticals：直近の展開
13.10 SOM Biotech
13.10.1 SOM Biotech：企業情報
13.10.2 SOM Biotech：ハンチントン病の治療製品ポートフォリオと特徴
13.10.3 SOM Biotech：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.10.4 SOM Biotech：主要事業概要
13.10.5 SOM Biotech：直近の展開
13.11 GlaxoSmithKline
13.11.1 GlaxoSmithKline：企業情報
13.11.2 GlaxoSmithKline：ハンチントン病の治療製品ポートフォリオと特徴
13.11.3 GlaxoSmithKline：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.11.4 GlaxoSmithKline：主要事業概要
13.11.5 GlaxoSmithKline：直近の展開
13.12 Siena Biotech
13.12.1 Siena Biotech：企業情報
13.12.2 Siena Biotech：ハンチントン病の治療製品ポートフォリオと特徴
13.12.3 Siena Biotech：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.12.4 Siena Biotech：主要事業概要
13.12.5 Siena Biotech：直近の展開
13.13 Raptor Pharmaceutical
13.13.1 Raptor Pharmaceutical：企業情報
13.13.2 Raptor Pharmaceutical：ハンチントン病の治療製品ポートフォリオと特徴
13.13.3 Raptor Pharmaceutical：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.13.4 Raptor Pharmaceutical：主要事業概要
13.13.5 Raptor Pharmaceutical：直近の展開
13.14 Pfizer
13.14.1 Pfizer：企業情報
13.14.2 Pfizer：ハンチントン病の治療製品ポートフォリオと特徴
13.14.3 Pfizer：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.14.4 Pfizer：主要事業概要
13.14.5 Pfizer：直近の展開
13.15 Palobiofarma
13.15.1 Palobiofarma：企業情報
13.15.2 Palobiofarma：ハンチントン病の治療製品ポートフォリオと特徴
13.15.3 Palobiofarma：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.15.4 Palobiofarma：主要事業概要
13.15.5 Palobiofarma：直近の展開
13.16 Omeros
13.16.1 Omeros：企業情報
13.16.2 Omeros：ハンチントン病の治療製品ポートフォリオと特徴
13.16.3 Omeros：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.16.4 Omeros：主要事業概要
13.16.5 Omeros：直近の展開
13.17 Ipsen
13.17.1 Ipsen：企業情報
13.17.2 Ipsen：ハンチントン病の治療製品ポートフォリオと特徴
13.17.3 Ipsen：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.17.4 Ipsen：主要事業概要
13.17.5 Ipsen：直近の展開
13.18 Valeant Pharmaceuticals International Inc
13.18.1 Valeant Pharmaceuticals International Inc：企業情報
13.18.2 Valeant Pharmaceuticals International Inc：ハンチントン病の治療製品ポートフォリオと特徴
13.18.3 Valeant Pharmaceuticals International Inc：ハンチントン病の治療売上・収益・価格およびグロスマージン（2018年～2023年）
13.18.4 Valeant Pharmaceuticals International Inc：主要事業概要
13.18.5 Valeant Pharmaceuticals International Inc：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
United States market for Huntington's Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Huntington's Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Huntington's Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Huntington's Disease Treatment players cover AInylam Pharmaceuticals Inc, AmpliPhi Biosciences Corp, Ceregene Inc, Lundbeck, Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd, Cortex Pharmaceuticals Inc, Vertex Pharmaceuticals Incorporated and Auspex Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Huntington's disease is an infrequent inherited neurodegenerative disease that affects various generations. The impact of this disease is high when the age is between 30 and 50, hampering their ability to work, care for families, and eventually complete daily tasks. The generality difers by more than ten-fold between geographical areas, which can be associated with differences in case ascertainments and diagnostic criteria. As a result, the generality of enlarged replications in the general population may be larger than expected. The Asian population has continuously had a lower generality, while Europe, North America, and Australia have a higher generality.
LPI (LP Information)' newest research report, the “Huntington's Disease Treatment Industry Forecast” looks at past sales and reviews total world Huntington's Disease Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Huntington's Disease Treatment sales for 2023 through 2029. With Huntington's Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Huntington's Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Huntington's Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Huntington's Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Huntington's Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Huntington's Disease Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Huntington's Disease Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Huntington's Disease Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tetrabenazine
Selective Serotonin Reuptake Inhibitor
Chlorpromazine
Haloperidol
Risperidone
Olanzapine
Clozapine
Other
Segmentation by application
Hospital
Specialty Clinic
other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AInylam Pharmaceuticals Inc
AmpliPhi Biosciences Corp
Ceregene Inc
Lundbeck
Prana Biotechnology Limited
Teva Pharmaceutical Industries Ltd
Cortex Pharmaceuticals Inc
Vertex Pharmaceuticals Incorporated
Auspex Pharmaceuticals
SOM Biotech
GlaxoSmithKline
Siena Biotech
Raptor Pharmaceutical
Pfizer
Palobiofarma
Omeros
Ipsen
Valeant Pharmaceuticals International Inc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Huntington's Disease Treatment market?
What factors are driving Huntington's Disease Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Huntington's Disease Treatment market opportunities vary by end market size?
How does Huntington's Disease Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Huntington's Disease Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Huntington's Disease Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Huntington's Disease Treatment by Country/Region, 2018, 2022 & 2029
2.2 Huntington's Disease Treatment Segment by Type
2.2.1 Tetrabenazine
2.2.2 Selective Serotonin Reuptake Inhibitor
2.2.3 Chlorpromazine
2.2.4 Haloperidol
2.2.5 Risperidone
2.2.6 Olanzapine
2.2.7 Clozapine
2.2.8 Other
2.3 Huntington's Disease Treatment Sales by Type
2.3.1 Global Huntington's Disease Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Huntington's Disease Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Huntington's Disease Treatment Sale Price by Type (2018-2023)
2.4 Huntington's Disease Treatment Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 other
2.5 Huntington's Disease Treatment Sales by Application
2.5.1 Global Huntington's Disease Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Huntington's Disease Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Huntington's Disease Treatment Sale Price by Application (2018-2023)
3 Global Huntington's Disease Treatment by Company
3.1 Global Huntington's Disease Treatment Breakdown Data by Company
3.1.1 Global Huntington's Disease Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Huntington's Disease Treatment Sales Market Share by Company (2018-2023)
3.2 Global Huntington's Disease Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Huntington's Disease Treatment Revenue by Company (2018-2023)
3.2.2 Global Huntington's Disease Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Huntington's Disease Treatment Sale Price by Company
3.4 Key Manufacturers Huntington's Disease Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Huntington's Disease Treatment Product Location Distribution
3.4.2 Players Huntington's Disease Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Huntington's Disease Treatment by Geographic Region
4.1 World Historic Huntington's Disease Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Huntington's Disease Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Huntington's Disease Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Huntington's Disease Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Huntington's Disease Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Huntington's Disease Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Huntington's Disease Treatment Sales Growth
4.4 APAC Huntington's Disease Treatment Sales Growth
4.5 Europe Huntington's Disease Treatment Sales Growth
4.6 Middle East & Africa Huntington's Disease Treatment Sales Growth
5 Americas
5.1 Americas Huntington's Disease Treatment Sales by Country
5.1.1 Americas Huntington's Disease Treatment Sales by Country (2018-2023)
5.1.2 Americas Huntington's Disease Treatment Revenue by Country (2018-2023)
5.2 Americas Huntington's Disease Treatment Sales by Type
5.3 Americas Huntington's Disease Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Huntington's Disease Treatment Sales by Region
6.1.1 APAC Huntington's Disease Treatment Sales by Region (2018-2023)
6.1.2 APAC Huntington's Disease Treatment Revenue by Region (2018-2023)
6.2 APAC Huntington's Disease Treatment Sales by Type
6.3 APAC Huntington's Disease Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Huntington's Disease Treatment by Country
7.1.1 Europe Huntington's Disease Treatment Sales by Country (2018-2023)
7.1.2 Europe Huntington's Disease Treatment Revenue by Country (2018-2023)
7.2 Europe Huntington's Disease Treatment Sales by Type
7.3 Europe Huntington's Disease Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Huntington's Disease Treatment by Country
8.1.1 Middle East & Africa Huntington's Disease Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Huntington's Disease Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Huntington's Disease Treatment Sales by Type
8.3 Middle East & Africa Huntington's Disease Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Huntington's Disease Treatment
10.3 Manufacturing Process Analysis of Huntington's Disease Treatment
10.4 Industry Chain Structure of Huntington's Disease Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Huntington's Disease Treatment Distributors
11.3 Huntington's Disease Treatment Customer
12 World Forecast Review for Huntington's Disease Treatment by Geographic Region
12.1 Global Huntington's Disease Treatment Market Size Forecast by Region
12.1.1 Global Huntington's Disease Treatment Forecast by Region (2024-2029)
12.1.2 Global Huntington's Disease Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Huntington's Disease Treatment Forecast by Type
12.7 Global Huntington's Disease Treatment Forecast by Application
13 Key Players Analysis
13.1 AInylam Pharmaceuticals Inc
13.1.1 AInylam Pharmaceuticals Inc Company Information
13.1.2 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolios and Specifications
13.1.3 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AInylam Pharmaceuticals Inc Main Business Overview
13.1.5 AInylam Pharmaceuticals Inc Latest Developments
13.2 AmpliPhi Biosciences Corp
13.2.1 AmpliPhi Biosciences Corp Company Information
13.2.2 AmpliPhi Biosciences Corp Huntington's Disease Treatment Product Portfolios and Specifications
13.2.3 AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AmpliPhi Biosciences Corp Main Business Overview
13.2.5 AmpliPhi Biosciences Corp Latest Developments
13.3 Ceregene Inc
13.3.1 Ceregene Inc Company Information
13.3.2 Ceregene Inc Huntington's Disease Treatment Product Portfolios and Specifications
13.3.3 Ceregene Inc Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ceregene Inc Main Business Overview
13.3.5 Ceregene Inc Latest Developments
13.4 Lundbeck
13.4.1 Lundbeck Company Information
13.4.2 Lundbeck Huntington's Disease Treatment Product Portfolios and Specifications
13.4.3 Lundbeck Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lundbeck Main Business Overview
13.4.5 Lundbeck Latest Developments
13.5 Prana Biotechnology Limited
13.5.1 Prana Biotechnology Limited Company Information
13.5.2 Prana Biotechnology Limited Huntington's Disease Treatment Product Portfolios and Specifications
13.5.3 Prana Biotechnology Limited Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Prana Biotechnology Limited Main Business Overview
13.5.5 Prana Biotechnology Limited Latest Developments
13.6 Teva Pharmaceutical Industries Ltd
13.6.1 Teva Pharmaceutical Industries Ltd Company Information
13.6.2 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.6.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.7 Cortex Pharmaceuticals Inc
13.7.1 Cortex Pharmaceuticals Inc Company Information
13.7.2 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolios and Specifications
13.7.3 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cortex Pharmaceuticals Inc Main Business Overview
13.7.5 Cortex Pharmaceuticals Inc Latest Developments
13.8 Vertex Pharmaceuticals Incorporated
13.8.1 Vertex Pharmaceuticals Incorporated Company Information
13.8.2 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product Portfolios and Specifications
13.8.3 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Vertex Pharmaceuticals Incorporated Main Business Overview
13.8.5 Vertex Pharmaceuticals Incorporated Latest Developments
13.9 Auspex Pharmaceuticals
13.9.1 Auspex Pharmaceuticals Company Information
13.9.2 Auspex Pharmaceuticals Huntington's Disease Treatment Product Portfolios and Specifications
13.9.3 Auspex Pharmaceuticals Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Auspex Pharmaceuticals Main Business Overview
13.9.5 Auspex Pharmaceuticals Latest Developments
13.10 SOM Biotech
13.10.1 SOM Biotech Company Information
13.10.2 SOM Biotech Huntington's Disease Treatment Product Portfolios and Specifications
13.10.3 SOM Biotech Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SOM Biotech Main Business Overview
13.10.5 SOM Biotech Latest Developments
13.11 GlaxoSmithKline
13.11.1 GlaxoSmithKline Company Information
13.11.2 GlaxoSmithKline Huntington's Disease Treatment Product Portfolios and Specifications
13.11.3 GlaxoSmithKline Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 GlaxoSmithKline Main Business Overview
13.11.5 GlaxoSmithKline Latest Developments
13.12 Siena Biotech
13.12.1 Siena Biotech Company Information
13.12.2 Siena Biotech Huntington's Disease Treatment Product Portfolios and Specifications
13.12.3 Siena Biotech Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Siena Biotech Main Business Overview
13.12.5 Siena Biotech Latest Developments
13.13 Raptor Pharmaceutical
13.13.1 Raptor Pharmaceutical Company Information
13.13.2 Raptor Pharmaceutical Huntington's Disease Treatment Product Portfolios and Specifications
13.13.3 Raptor Pharmaceutical Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Raptor Pharmaceutical Main Business Overview
13.13.5 Raptor Pharmaceutical Latest Developments
13.14 Pfizer
13.14.1 Pfizer Company Information
13.14.2 Pfizer Huntington's Disease Treatment Product Portfolios and Specifications
13.14.3 Pfizer Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Pfizer Main Business Overview
13.14.5 Pfizer Latest Developments
13.15 Palobiofarma
13.15.1 Palobiofarma Company Information
13.15.2 Palobiofarma Huntington's Disease Treatment Product Portfolios and Specifications
13.15.3 Palobiofarma Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Palobiofarma Main Business Overview
13.15.5 Palobiofarma Latest Developments
13.16 Omeros
13.16.1 Omeros Company Information
13.16.2 Omeros Huntington's Disease Treatment Product Portfolios and Specifications
13.16.3 Omeros Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Omeros Main Business Overview
13.16.5 Omeros Latest Developments
13.17 Ipsen
13.17.1 Ipsen Company Information
13.17.2 Ipsen Huntington's Disease Treatment Product Portfolios and Specifications
13.17.3 Ipsen Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Ipsen Main Business Overview
13.17.5 Ipsen Latest Developments
13.18 Valeant Pharmaceuticals International Inc
13.18.1 Valeant Pharmaceuticals International Inc Company Information
13.18.2 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product Portfolios and Specifications
13.18.3 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Valeant Pharmaceuticals International Inc Main Business Overview
13.18.5 Valeant Pharmaceuticals International Inc Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Huntington's Disease Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Huntington's Disease Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Tetrabenazine Table 4. Major Players of Selective Serotonin Reuptake Inhibitor Table 5. Major Players of Chlorpromazine Table 6. Major Players of Haloperidol Table 7. Major Players of Risperidone Table 8. Major Players of Olanzapine Table 9. Major Players of Clozapine Table 10. Major Players of Other Table 11. Global Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units) Table 12. Global Huntington's Disease Treatment Sales Market Share by Type (2018-2023) Table 13. Global Huntington's Disease Treatment Revenue by Type (2018-2023) & ($ million) Table 14. Global Huntington's Disease Treatment Revenue Market Share by Type (2018-2023) Table 15. Global Huntington's Disease Treatment Sale Price by Type (2018-2023) & (US$/Unit) Table 16. Global Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units) Table 17. Global Huntington's Disease Treatment Sales Market Share by Application (2018-2023) Table 18. Global Huntington's Disease Treatment Revenue by Application (2018-2023) Table 19. Global Huntington's Disease Treatment Revenue Market Share by Application (2018-2023) Table 20. Global Huntington's Disease Treatment Sale Price by Application (2018-2023) & (US$/Unit) Table 21. Global Huntington's Disease Treatment Sales by Company (2018-2023) & (K Units) Table 22. Global Huntington's Disease Treatment Sales Market Share by Company (2018-2023) Table 23. Global Huntington's Disease Treatment Revenue by Company (2018-2023) ($ Millions) Table 24. Global Huntington's Disease Treatment Revenue Market Share by Company (2018-2023) Table 25. Global Huntington's Disease Treatment Sale Price by Company (2018-2023) & (US$/Unit) Table 26. Key Manufacturers Huntington's Disease Treatment Producing Area Distribution and Sales Area Table 27. Players Huntington's Disease Treatment Products Offered Table 28. Huntington's Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 29. New Products and Potential Entrants Table 30. Mergers & Acquisitions, Expansion Table 31. Global Huntington's Disease Treatment Sales by Geographic Region (2018-2023) & (K Units) Table 32. Global Huntington's Disease Treatment Sales Market Share Geographic Region (2018-2023) Table 33. Global Huntington's Disease Treatment Revenue by Geographic Region (2018-2023) & ($ millions) Table 34. Global Huntington's Disease Treatment Revenue Market Share by Geographic Region (2018-2023) Table 35. Global Huntington's Disease Treatment Sales by Country/Region (2018-2023) & (K Units) Table 36. Global Huntington's Disease Treatment Sales Market Share by Country/Region (2018-2023) Table 37. Global Huntington's Disease Treatment Revenue by Country/Region (2018-2023) & ($ millions) Table 38. Global Huntington's Disease Treatment Revenue Market Share by Country/Region (2018-2023) Table 39. Americas Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units) Table 40. Americas Huntington's Disease Treatment Sales Market Share by Country (2018-2023) Table 41. Americas Huntington's Disease Treatment Revenue by Country (2018-2023) & ($ Millions) Table 42. Americas Huntington's Disease Treatment Revenue Market Share by Country (2018-2023) Table 43. Americas Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units) Table 44. Americas Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units) Table 45. APAC Huntington's Disease Treatment Sales by Region (2018-2023) & (K Units) Table 46. APAC Huntington's Disease Treatment Sales Market Share by Region (2018-2023) Table 47. APAC Huntington's Disease Treatment Revenue by Region (2018-2023) & ($ Millions) Table 48. APAC Huntington's Disease Treatment Revenue Market Share by Region (2018-2023) Table 49. APAC Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units) Table 50. APAC Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units) Table 51. Europe Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units) Table 52. Europe Huntington's Disease Treatment Sales Market Share by Country (2018-2023) Table 53. Europe Huntington's Disease Treatment Revenue by Country (2018-2023) & ($ Millions) Table 54. Europe Huntington's Disease Treatment Revenue Market Share by Country (2018-2023) Table 55. Europe Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units) Table 56. Europe Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units) Table 57. Middle East & Africa Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units) Table 58. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Country (2018-2023) Table 59. Middle East & Africa Huntington's Disease Treatment Revenue by Country (2018-2023) & ($ Millions) Table 60. Middle East & Africa Huntington's Disease Treatment Revenue Market Share by Country (2018-2023) Table 61. Middle East & Africa Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units) Table 62. Middle East & Africa Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units) Table 63. Key Market Drivers & Growth Opportunities of Huntington's Disease Treatment Table 64. Key Market Challenges & Risks of Huntington's Disease Treatment Table 65. Key Industry Trends of Huntington's Disease Treatment Table 66. Huntington's Disease Treatment Raw Material Table 67. Key Suppliers of Raw Materials Table 68. Huntington's Disease Treatment Distributors List Table 69. Huntington's Disease Treatment Customer List Table 70. Global Huntington's Disease Treatment Sales Forecast by Region (2024-2029) & (K Units) Table 71. Global Huntington's Disease Treatment Revenue Forecast by Region (2024-2029) & ($ millions) Table 72. Americas Huntington's Disease Treatment Sales Forecast by Country (2024-2029) & (K Units) Table 73. Americas Huntington's Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions) Table 74. APAC Huntington's Disease Treatment Sales Forecast by Region (2024-2029) & (K Units) Table 75. APAC Huntington's Disease Treatment Revenue Forecast by Region (2024-2029) & ($ millions) Table 76. Europe Huntington's Disease Treatment Sales Forecast by Country (2024-2029) & (K Units) Table 77. Europe Huntington's Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions) Table 78. Middle East & Africa Huntington's Disease Treatment Sales Forecast by Country (2024-2029) & (K Units) Table 79. Middle East & Africa Huntington's Disease Treatment Revenue Forecast by Country (2024-2029) & ($ millions) Table 80. Global Huntington's Disease Treatment Sales Forecast by Type (2024-2029) & (K Units) Table 81. Global Huntington's Disease Treatment Revenue Forecast by Type (2024-2029) & ($ Millions) Table 82. Global Huntington's Disease Treatment Sales Forecast by Application (2024-2029) & (K Units) Table 83. Global Huntington's Disease Treatment Revenue Forecast by Application (2024-2029) & ($ Millions) Table 84. AInylam Pharmaceuticals Inc Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 85. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolios and Specifications Table 86. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 87. AInylam Pharmaceuticals Inc Main Business Table 88. AInylam Pharmaceuticals Inc Latest Developments Table 89. AmpliPhi Biosciences Corp Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 90. AmpliPhi Biosciences Corp Huntington's Disease Treatment Product Portfolios and Specifications Table 91. AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 92. AmpliPhi Biosciences Corp Main Business Table 93. AmpliPhi Biosciences Corp Latest Developments Table 94. Ceregene Inc Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 95. Ceregene Inc Huntington's Disease Treatment Product Portfolios and Specifications Table 96. Ceregene Inc Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 97. Ceregene Inc Main Business Table 98. Ceregene Inc Latest Developments Table 99. Lundbeck Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 100. Lundbeck Huntington's Disease Treatment Product Portfolios and Specifications Table 101. Lundbeck Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 102. Lundbeck Main Business Table 103. Lundbeck Latest Developments Table 104. Prana Biotechnology Limited Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 105. Prana Biotechnology Limited Huntington's Disease Treatment Product Portfolios and Specifications Table 106. Prana Biotechnology Limited Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 107. Prana Biotechnology Limited Main Business Table 108. Prana Biotechnology Limited Latest Developments Table 109. Teva Pharmaceutical Industries Ltd Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 110. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product Portfolios and Specifications Table 111. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 112. Teva Pharmaceutical Industries Ltd Main Business Table 113. Teva Pharmaceutical Industries Ltd Latest Developments Table 114. Cortex Pharmaceuticals Inc Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 115. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolios and Specifications Table 116. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 117. Cortex Pharmaceuticals Inc Main Business Table 118. Cortex Pharmaceuticals Inc Latest Developments Table 119. Vertex Pharmaceuticals Incorporated Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 120. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product Portfolios and Specifications Table 121. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 122. Vertex Pharmaceuticals Incorporated Main Business Table 123. Vertex Pharmaceuticals Incorporated Latest Developments Table 124. Auspex Pharmaceuticals Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 125. Auspex Pharmaceuticals Huntington's Disease Treatment Product Portfolios and Specifications Table 126. Auspex Pharmaceuticals Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 127. Auspex Pharmaceuticals Main Business Table 128. Auspex Pharmaceuticals Latest Developments Table 129. SOM Biotech Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 130. SOM Biotech Huntington's Disease Treatment Product Portfolios and Specifications Table 131. SOM Biotech Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 132. SOM Biotech Main Business Table 133. SOM Biotech Latest Developments Table 134. GlaxoSmithKline Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 135. GlaxoSmithKline Huntington's Disease Treatment Product Portfolios and Specifications Table 136. GlaxoSmithKline Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 137. GlaxoSmithKline Main Business Table 138. GlaxoSmithKline Latest Developments Table 139. Siena Biotech Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 140. Siena Biotech Huntington's Disease Treatment Product Portfolios and Specifications Table 141. Siena Biotech Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 142. Siena Biotech Main Business Table 143. Siena Biotech Latest Developments Table 144. Raptor Pharmaceutical Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 145. Raptor Pharmaceutical Huntington's Disease Treatment Product Portfolios and Specifications Table 146. Raptor Pharmaceutical Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 147. Raptor Pharmaceutical Main Business Table 148. Raptor Pharmaceutical Latest Developments Table 149. Pfizer Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 150. Pfizer Huntington's Disease Treatment Product Portfolios and Specifications Table 151. Pfizer Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 152. Pfizer Main Business Table 153. Pfizer Latest Developments Table 154. Palobiofarma Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 155. Palobiofarma Huntington's Disease Treatment Product Portfolios and Specifications Table 156. Palobiofarma Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 157. Palobiofarma Main Business Table 158. Palobiofarma Latest Developments Table 159. Omeros Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 160. Omeros Huntington's Disease Treatment Product Portfolios and Specifications Table 161. Omeros Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 162. Omeros Main Business Table 163. Omeros Latest Developments Table 164. Ipsen Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 165. Ipsen Huntington's Disease Treatment Product Portfolios and Specifications Table 166. Ipsen Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 167. Ipsen Main Business Table 168. Ipsen Latest Developments Table 169. Valeant Pharmaceuticals International Inc Basic Information, Huntington's Disease Treatment Manufacturing Base, Sales Area and Its Competitors Table 170. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product Portfolios and Specifications Table 171. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 172. Valeant Pharmaceuticals International Inc Main Business Table 173. Valeant Pharmaceuticals International Inc Latest Developments List of Figures Figure 1. Picture of Huntington's Disease Treatment Figure 2. Huntington's Disease Treatment Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Huntington's Disease Treatment Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Huntington's Disease Treatment Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Huntington's Disease Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Tetrabenazine Figure 10. Product Picture of Selective Serotonin Reuptake Inhibitor Figure 11. Product Picture of Chlorpromazine Figure 12. Product Picture of Haloperidol Figure 13. Product Picture of Risperidone Figure 14. Product Picture of Olanzapine Figure 15. Product Picture of Clozapine Figure 16. Product Picture of Other Figure 17. Global Huntington's Disease Treatment Sales Market Share by Type in 2022 Figure 18. Global Huntington's Disease Treatment Revenue Market Share by Type (2018-2023) Figure 19. Huntington's Disease Treatment Consumed in Hospital Figure 20. Global Huntington's Disease Treatment Market: Hospital (2018-2023) & (K Units) Figure 21. Huntington's Disease Treatment Consumed in Specialty Clinic Figure 22. Global Huntington's Disease Treatment Market: Specialty Clinic (2018-2023) & (K Units) Figure 23. Huntington's Disease Treatment Consumed in other Figure 24. Global Huntington's Disease Treatment Market: other (2018-2023) & (K Units) Figure 25. Global Huntington's Disease Treatment Sales Market Share by Application (2022) Figure 26. Global Huntington's Disease Treatment Revenue Market Share by Application in 2022 Figure 27. Huntington's Disease Treatment Sales Market by Company in 2022 (K Units) Figure 28. Global Huntington's Disease Treatment Sales Market Share by Company in 2022 Figure 29. Huntington's Disease Treatment Revenue Market by Company in 2022 ($ Million) Figure 30. Global Huntington's Disease Treatment Revenue Market Share by Company in 2022 Figure 31. Global Huntington's Disease Treatment Sales Market Share by Geographic Region (2018-2023) Figure 32. Global Huntington's Disease Treatment Revenue Market Share by Geographic Region in 2022 Figure 33. Americas Huntington's Disease Treatment Sales 2018-2023 (K Units) Figure 34. Americas Huntington's Disease Treatment Revenue 2018-2023 ($ Millions) Figure 35. APAC Huntington's Disease Treatment Sales 2018-2023 (K Units) Figure 36. APAC Huntington's Disease Treatment Revenue 2018-2023 ($ Millions) Figure 37. Europe Huntington's Disease Treatment Sales 2018-2023 (K Units) Figure 38. Europe Huntington's Disease Treatment Revenue 2018-2023 ($ Millions) Figure 39. Middle East & Africa Huntington's Disease Treatment Sales 2018-2023 (K Units) Figure 40. Middle East & Africa Huntington's Disease Treatment Revenue 2018-2023 ($ Millions) Figure 41. Americas Huntington's Disease Treatment Sales Market Share by Country in 2022 Figure 42. Americas Huntington's Disease Treatment Revenue Market Share by Country in 2022 Figure 43. Americas Huntington's Disease Treatment Sales Market Share by Type (2018-2023) Figure 44. Americas Huntington's Disease Treatment Sales Market Share by Application (2018-2023) Figure 45. United States Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 46. Canada Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 47. Mexico Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 48. Brazil Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 49. APAC Huntington's Disease Treatment Sales Market Share by Region in 2022 Figure 50. APAC Huntington's Disease Treatment Revenue Market Share by Regions in 2022 Figure 51. APAC Huntington's Disease Treatment Sales Market Share by Type (2018-2023) Figure 52. APAC Huntington's Disease Treatment Sales Market Share by Application (2018-2023) Figure 53. China Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 54. Japan Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 55. South Korea Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 56. Southeast Asia Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 57. India Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 58. Australia Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 59. China Taiwan Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 60. Europe Huntington's Disease Treatment Sales Market Share by Country in 2022 Figure 61. Europe Huntington's Disease Treatment Revenue Market Share by Country in 2022 Figure 62. Europe Huntington's Disease Treatment Sales Market Share by Type (2018-2023) Figure 63. Europe Huntington's Disease Treatment Sales Market Share by Application (2018-2023) Figure 64. Germany Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 65. France Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 66. UK Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 67. Italy Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 68. Russia Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 69. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Country in 2022 Figure 70. Middle East & Africa Huntington's Disease Treatment Revenue Market Share by Country in 2022 Figure 71. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Type (2018-2023) Figure 72. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Application (2018-2023) Figure 73. Egypt Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 74. South Africa Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 75. Israel Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 76. Turkey Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 77. GCC Country Huntington's Disease Treatment Revenue Growth 2018-2023 ($ Millions) Figure 78. Manufacturing Cost Structure Analysis of Huntington's Disease Treatment in 2022 Figure 79. Manufacturing Process Analysis of Huntington's Disease Treatment Figure 80. Industry Chain Structure of Huntington's Disease Treatment Figure 81. Channels of Distribution Figure 82. Global Huntington's Disease Treatment Sales Market Forecast by Region (2024-2029) Figure 83. Global Huntington's Disease Treatment Revenue Market Share Forecast by Region (2024-2029) Figure 84. Global Huntington's Disease Treatment Sales Market Share Forecast by Type (2024-2029) Figure 85. Global Huntington's Disease Treatment Revenue Market Share Forecast by Type (2024-2029) Figure 86. Global Huntington's Disease Treatment Sales Market Share Forecast by Application (2024-2029) Figure 87. Global Huntington's Disease Treatment Revenue Market Share Forecast by Application (2024-2029)
